Growth, Trends, and Opportunities in the Multiplex PCR Assays Market: Key Insights for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Long-Term Projected Growth Rate for the Multiplex PCR Assays Market, and What Are the Key Drivers?
The market size of multiplex pcr assays has risen quickly in the past few years. Growth is expected from $1.51 billion in 2024 to $1.72 billion in 2025, with a compound annual growth rate (CAGR) of 13.6%. The boost in this sector over the historical period is due to factors such as the rising prevalence of infectious diseases, amplified government funding and support, growing application in clinical diagnostics, surge in genetic testing and personalized medicine, heightened use in academic and research institutions, progress in bioinformatics and analytical tools, along with an increase in healthcare expenditure.
The market size for multiplex pcr assays is predicted to undergo significant expansion in the coming years, ballooning to a valuation of $2.83 billion in 2029 with a compound annual growth rate (CAGR) of 13.4%. The primary factors contributing to this predicted growth over the forecast period are wider application areas, increasing demand for point-of-care diagnostics, the proliferation of personalized medicine, growth in research and development spending, heightened health consciousness and preventive health measures, a laser focus on precision medicine and an upsurge in the necessity for quick and reliable diagnostic tests. The forecasted period is likely to witness trends like the incorporation of next-generation sequencing (NGS), companion diagnostics, digital PCR technology, automation and high-throughput systems, portable and point-of-care devices, customization and multiplexing capabilities, artificial intelligence and machine learning adaptation, enhanced data management, and the implementation of cloud solutions.
What Strategic Factors Are Influencing the Accelerated Growth of the Multiplex PCR Assays Market?
A surge in the need for diagnostic testing is anticipated to inject momentum into the expansion of the multiplex PCR assay market. Diagnostic testing, which involves a series of processes or evaluations to verify the existence or non-existence of a medical condition or disease in a patient, is experiencing a surge in demand. This increment is sparked by the rise in chronic diseases such as cancer and diabetes that necessitate prompt and precise diagnosis for effective control. In addition, the emphasis on preventive healthcare promotes regular testing to identify potential problems at an early stage. Multiplex PCR assays enhance the efficiency and thoroughness of diagnostic testing by enabling the concurrent detection and analysis of multiple pathogens or genetic markers from a single specimen. For example, the National Health Service (NHS), a healthcare provider and hospital based in the U.K., reported in July 2024 that diagnostic activity surpassed pre-pandemic levels in 2023, recording an increment of 21% in the tests conducted in May 2024 compared to the same period of the previous year. Furthermore, there were 2.4 million diagnostic tests carried out in May 2024. This escalating requirement for diagnostic testing is expected to fuel the growth of the multiplex PCR assay market.
Explore Comprehensive Insights Into The Global Multiplex PCR Assays Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18681&type=smp
Which Companies Are Leading the Charge in Expanding the Multiplex PCR Assays Market?
Major companies operating in the multiplex PCR assays market are:
• F. Hoffmann-La Roche Ltd_x000D_
• Thermo Fisher Scientific Inc_x000D_
• Abbott Laboratories_x000D_
• Danaher Corporation_x000D_
• Merck KGaA_x000D_
What New Trends Are Reshaping the Multiplex PCR Assays Market and Its Opportunities?
Key players in the multiplex PCR assays market are prioritizing the incorporation of automation, for example, next-generation quantitative PCR (qPCR) systems, to offer exact and versatile nucleic acid quantification for refined clinical diagnostics and public health. These next-generation qPCR systems deliver high-throughput, precise, and collective detection of numerous targets, boosting diagnostic precision and efficacy. An illustration of this came in November 2023 when Roche Diagnostics Corporation, a company based in Switzerland that manufactures diagnostic system solutions, introduced the LightCycler PRO System. This state-of-the-art qPCR platform has the capacity for high-throughput, accurate, and concurrent detection of various targets. With improved temperature uniformity, innovative software, and compatibility with over 200 LightMix Modular and 60 CE-IVD assays, it enhances diagnostic precision and efficacy. This system represents the merging of automation in the Multiplex PCR Assays market, propelling clinical diagnostics and public health forward.
Secure Your Global Multiplex PCR Assays Market Report Now for Fast and Efficient Delivery!
https://www.thebusinessresearchcompany.com/report/multiplex-pcr-assays-global-market-report
Which Key Market Segments Comprise the Multiplex PCR Assays Market and Drive Its Revenue Growth?
The multiplex pcr assays market covered in this report is segmented –
1) By Assay Type: Planar Assay, Bead Based Assay
2) By Product And Services: Consumables, Instruments, Software And Services
3) By Application: Disease Diagnosis, Research And Development, Other Applications
4) By End User: Biopharmaceutical Companies, Clinical Research Organizations, Academic Research Institutes, Diagnostic Centers, Other End Users
Subsegments:
1) By Planar Assay: Microarray-Based Assays, Dna Chip-Based Assays
2) By Bead Based Assay: Luminex Xmap Assays, Magpix Assays, Flow Cytometry-Based Bead Assays
What Are the Top Regions Fueling Growth in the Multiplex PCR Assays Market?
North America was the largest region in the multiplex PCR assays market in 2024. The regions covered in the multiplex PCR assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Multiplex PCR Assays Market Defined Across Different Regions?
Multiplex PCR assays refer to a type of polymerase chain reaction (PCR) technique that allows simultaneous amplification and detection of multiple DNA or RNA targets within a single reaction. This method enhances efficiency by enabling the analysis of several genetic markers or pathogens in one test, providing comprehensive and cost-effective results.
Browse Through More Similar Reports By The Business Research Company:
Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024
Adenosine Triphosphate (ATP) Assays Global Market Report 2024
Protein Assays Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
